ANAB vs ECL · rev $91.3M vs P/E 35, rev $4.01B
AnaptysBio Inc (ANAB) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ANAB currently screens at market cap $1.62B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ANAB and ECL stock pages for the full models.
Not investment advice.